IP Library Granted Patent US 7,087,148
Granted Patent B1
US 7,087,148 · App. 09/712,792 · Granted Aug 8, 2006

Binding acceleration techniques for the detection of analytes

Assignee: Clinical Micro Sensors, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,087,148
App. No.
09/712,792
Granted
Aug 8, 2006
Kind
B1
Abstract

The invention relates to compositions and methods useful in the acceleration of binding of target analytes to capture ligands on surfaces. Detection proceeds through the use of an electron transfer moiety (ETM) that is associated with the target analyte, either directly or indirectly, to allow electronic detection of the ETM.

Claims (61)

1. A device comprising a substrate comprising:

a) a first surface comprising:

i) an array of detection electrodes each comprising a covalently attached capture ligand;

ii) at least a first electrophoresis electrode;

b) a second surface comprising at least a second electrophoresis electrode; and

c) at least one channel connecting said first surface and second surface.

2. A device according to claim 1 wherein said channel comprises a permeation layer material.

3. A device according to claim 2 wherein said channel comprises a membrane.

4. A device according to claim 1 further comprising a detection chamber, wherein said detection chamber comprises said surfaces.

5. A device according to claim 1 wherein said detection electrodes further comprise a self-assembled monolayer.

6. A device according to claim 1 wherein said substrate is Printed Circuit (PC) board.

7. A device according to claim 1 wherein said capture ligand is nucleic acid.

8. A device comprising a detection chamber comprising:

a) a first subchamber comprising an array of detection electrodes each comprising a covalently attached capture ligand;

b) a second subchamber comprising an absorbent material; and

c) a substrate comprising:

i) a first surface in contact with said array of detection electrodes;

ii) a second surface in contact with said absorbent material;

iii) at least one channel connecting said first surface and said second surface; and

iv) a size exclusion partition at either end of said at least one channel.

9. A device according to claim 8 wherein said channel comprises a permeation layer material.

10. A device according to claim 8 wherein said channel comprises a membrane.

11. A device according to claim 8 wherein said detection electrodes further comprise a self-assembled monolayer.

12. A device according to claim 8 wherein said substrate is PC board.

13. A device according to claim 8 wherein said capture ligand is nucleic acid.

14. The device according to claim 8 , wherein said size exclusion partition is in contact with said first surface.

15. The device according to claim 8 , wherein said size exclusion partition is in contact with said second surface.

16. The device according to claim 8 , wherein said size exclusion partition is a semi-permeable membrane.

17. A method of detecting a target analyte in a sample comprising:

a) concentrating said target analyte in a detection chamber comprising:

i) a first surface comprising:

1) an array of detection electrodes each comprising a covalently attached capture ligand;

2) at least a first electrophoresis electrode;

ii) a second surface comprising at least a second electrophoresis electrode; and

iii) at least one channel connecting said first surface and second surface;

b) binding said target analyte to said capture ligand to form an assay complex, wherein said assay complex further comprises at least one electron transfer moiety (ETM); and

c) detecting the presence of said ETM using said detection electrode.

18. A method according to claim 17 wherein said detection electrodes further comprise a self-assembled monolayer.

19. A method according to claim 17 wherein said detection chamber further comprises a substrate.

20. A method according to claim 19 wherein said substrate is a PC board.

21. A method according to claim 17 wherein said capture ligand is nucleic acid.

22. A method according to claim 17 wherein said assay complex comprises said target analyte, said capture ligand, and a label probe and wherein said label probe comprises said ETM.

23. A method according to claim 17 wherein said assay complex comprises said target analyte and said capture ligand and said target analyte comprises said ETM.

24. A method according to claim 17 wherein said ETM is a transition metal complex.

25. A method of detecting a target analyte in a sample comprising:

a) concentrating said target analyte in a detection chamber comprising:

i) a substrate comprising:

1) a first surface comprising:

A) an array of detection electrodes each comprising a covalently attached capture ligand;

2) a second surface;

3) at least one channel connecting said first surface and second surface; and

ii) an absorbent material in contact with said second surface;

b) binding said target analyte to said capture ligand to form an assay complex, wherein said assay complex further comprises at least one electron transfer moiety (ETM); and

c) detecting the presence of said ETM using said detection electrode.

26. A method according to claim 25 wherein said detection electrodes further comprise a self-assembled monolayer.

27. A method according to claim 25 wherein said substrate is PC board.

28. A method according to claim 25 wherein said capture ligand is nucleic acid.

29. A method according to claim 25 wherein said assay complex comprises said target analyte, said capture ligand, and a label probe and wherein said label probe comprises said ETM.

30. A method according to claim 25 wherein said assay complex comprises said target analyte and said capture ligand and said target analyte comprises said ETM.

31. A method according to claim 25 wherein said ETM is a transition metal complex.

32. The method according to claim 25 wherein said detection chamber further comprises a size exclusion partition at either end of said at least one channel.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2012
From: SQUARE 1 BANK
To: OSMETECH TECHNOLOGY, INC.
Reel/Frame 029097/0148 →
SECURITY INTEREST Recorded Apr 1, 2010
From: OSMETECH TECHNOLOGY INC.
To: SQUARE 1 BANK
Reel/Frame 024312/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2008
From: CLINICAL MICRO SENSORS INC. (DBA OSMETECH MOLECULAR DIAGNOSTICS)
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 021924/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2001
From: BLACKBURN, GARY; VIELMETTER, JOST G.; KAYYEM, JON FAIZ
To: CLINICAL MICRO SENSORS, INC.
Reel/Frame 011780/0636 →
Continuity (5)
Continuation In Part 0944037100 · Nov 12, 1999
Continuation In Part 0933872600 · Jun 23, 1999
Continuation In Part 0913405800 · Aug 14, 1998
Provisional Application 6017198100 · Dec 23, 1999
Provisional Application 6009038900 · Jun 23, 1998